Prediction model incorporating dynamic changes in serum tumor markers for evaluating the efficacy of neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study
Xiaoqian Li, Junjie Liu, Zirui Wang, Xiaoduo Li, Kexuan Feng, Rui Zhang, Jianjun He, Huimin Zhang · 2025
Read Prediction model incorporating dynamic changes in serum tumor markers for evaluating the efficacy of neoadjuvant chemotherapy in patients with breast cancer: a retrospective cohort study by Xiaoqian Li, Junjie Liu, Zirui Wang, Xiaoduo Li, Kexuan Feng, Rui Zhang, Jianjun He, Huimin Zhang (2025) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-12699848.txt.
Description
Xiaoqian Li and seven co-authors built a model to judge how well pre-surgery chemotherapy works in breast cancer, in a study from twenty twenty-five. Most older models use a single blood test taken before treatment. Changes in tumor markers during treatment carry extra signal that had gone unused.
Records of hundreds of patients at one hospital were split into building and testing groups. The final chart mixes age, a growth-receptor status, starting marker levels, and summaries of how three markers moved over time. It beat a rival chart built only on starting values in both groups. Checks of its risk estimates and clinical usefulness also looked sound. The authors say tracking markers over time sharpens prediction.
Catalog record
| CREATOR | Xiaoqian Li, Junjie Liu, Zirui Wang, Xiaoduo Li, Kexuan Feng, Rui Zhang, Jianjun He, Huimin Zhang |
|---|---|
| YEAR | 2025 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 51 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |